Effects of acute-liver-failure-plasma exposure on hepatic functionality of HepaRG-AMC-Bioartificial Liver

Liver International

Volumn 33, Issue 4, 2013, Pages 516-524

  Nibourg, Geert A A ^a   Hoekstra, Ruurdtje ^a   van der Hoeven, Tessa V ^a   Ackermans, Mariëtte T ^a   Hakvoort, Theodorus B M ^a   van Gulik, Thomas M ^a   Chamuleau, Robert A F M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

AMC BAL; Fulminant hepatic failure; Liver assist device; Liver support; Toxicity

Indexed keywords

AMMONIA; APOLIPOPROTEIN A1; ARGINASE; CYTOCHROME P450 3A4; UREA;

ACUTE LIVER FAILURE; ADULT; AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOARTIFICIAL LIVER; CASE REPORT; CIRCULATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE; GENETIC TRANSCRIPTION; GLUCOSE INTAKE; GLUCOSE METABOLISM; HUMAN; LIVER FUNCTION; LIVER ISCHEMIA; NONHUMAN; RAT;

AMINO ACIDS; AMMONIA; ANIMALS; APOLIPOPROTEIN A-I; CELL LINE, TUMOR; CYTOCHROME P-450 CYP3A; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; LIVER; LIVER FAILURE, ACUTE; LIVER, ARTIFICIAL; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TRANSCRIPTION, GENETIC; UREA;

EID: 84875054857     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12090     Document Type: Article

References (39)

1. Carpentier B, Gautier A, Legallais C. Artificial and bioartificial liver devices: present and future. Gut 2009; 58: 1690-1702.
2. Bernal W, Auzinger G, Dhawan AA. Acute liver failure. Lancet 2010; 376: 190-201.
3. Nibourg GA, Chamuleau RA, van der Hoeven TV, et al. Liver Progenitor Cell Line HepaRG Differentiated in a Bioartificial Liver Effectively Supplies Liver Support to Rats with Acute Liver Failure. PLoS ONE 2012; 7: e38778.
4. Cerec V, Glaise D, Garnier D, et al. Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor. Hepatology 2007; 45: 957-67.
5. Flendrig LM, la Soe JW, Jorning GG, et al. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates. J Hepatol 1997; 26: 1379-92.
6. Gripon P, Rumin S, Urban S, et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci USA 2002; 99: 15655-60.
7. Hoekstra R, Nibourg GA, van der Hoeven TV, et al. The HepaRG cell line is suitable for bioartificial liver application. Int J Biochem Cell Biol 2011; 43: 1483-89.
8. Hughes RD, Cochrane AM, Thomson AD, et al. The cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes. Br J Exp Pathol 1976; 57: 348-53.
9. Abdel-Razzak Z, Loyer P, Fautrel A, et al. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 1993; 44: 707-15.
10. Catapano G, De Bartolo L, Lombardi CP, et al. The effect of catabolite concentration on the viability and functions of isolated rat hepatocytes. Int J Artif Organs 1996; 19: 245-50.
11. Pagani R, Portoles MT, az-Laviada I, et al. Morphological damage induced by Escherichia coli lipopolysaccharide in cultured hepatocytes: localization and binding properties. Br J Exp Pathol 1988; 69: 537-49.
12. Smirthwaite AD, Gaylor JD, Cousins RB, et al. Cytotoxicity of bile in human Hep G2 cells and in primary cultures of rat hepatocytes. Artif Organs 1998; 22: 831-36.
13. Grant MH, Rodgers EH, Anderson K, et al. The effect of serum from liver cancer patients on the growth and function of primary and immortalised hepatocytes. Int J Artif Organs 2001; 24: 807-13.
14. Newsome PN, Tsiaoussis J, Masson S, et al. Serum from patients with fulminant hepatic failure causes hepatocyte detachment and apoptosis by a beta(1)-integrin pathway. Hepatology 2004; 40: 636-45.
15. Shi Q, Gaylor JD, Cousins R, et al. The effects of serum from patients with acute liver failure on the growth and metabolism of Hep G2 cells. Artif Organs 1998; 22: 1023-30.
16. Yamada H, Toda G, Yoshiba M, et al. Humoral inhibitor of rat hepatocyte DNA synthesis from patients with fulminant liver failure. Hepatology 1994; 19: 1133-40.
17. Abrahamse SL, van de Kerkhove MP, Sosef MN, et al. Treatment of acute liver failure in pigs reduces hepatocyte function in a bioartificial liver support system. Int J Artif Organs 2002; 25: 966-74.
18. Ito Y, Eguchi S, Kamohara Y, et al. Influence of serum from rats with fulminant hepatic failure on hepatocytes in a bioartificial liver system. Int J Artif Organs 2004; 27: 303-10.
19. Nagaki M, Imose M, Naiki T, et al. Prospective study on early virologic response to treatment with interferon alpha-2b plus ribavirin in patients with chronic hepatitis C genotype 1b. Hepatol Res 2005; 33: 285-91.
20. Papadimitriou D, Arkadopoulos N, Kouskouni E, et al. Hepatocyte function during experimental use of a bioartificial liver. Transplant Proc 2004; 36: 1741-43.
21. Hoekstra R, Nibourg GAA, Van der Hoeven TV, et al. The effect of rat acute liver failure plasma on HepaRG cells. Int J Artif Organs 2012; 35: 1006-14.
22. Mavri-Damelin D, Damelin LH, Eaton S, et al. Cells for bioartificial liver devices: the human hepatoma-derived cell line C3A produces urea but does not detoxify ammonia. Biotechnol Bioeng 2008; 99: 644-51.
23. Morris SM Jr. Recent advances in arginine metabolism: roles and regulation of the arginases. Br J Pharmacol 2009; 157: 922-30.
24. Nibourg GA, Huisman MT, van der Hoeven TV, et al. Stable overexpression of Pregnane X receptor in HepG2 cells increases its potential for bioartificial liver application. Liver Transpl 2010; 16: 1075-85.
25. Poyck PP, Hoekstra R, Chhatta A, et al. Time-related analysis of metabolic liver functions, cellular morphology, and gene expression of hepatocytes cultured in the bioartificial liver of the Academic Medical Center in Amsterdam (AMC-BAL). Tissue Eng 2007; 13: 1235-46.
26. Hoekstra R, Deurholt T, ten Bloemendaal L, et al. Assessment of in vitro applicability of reversibly immortalized NKNT-3 cells and clonal derivatives. Cell Transplant 2006; 15: 423-33.
27. Deurholt T, van Til NP, Chhatta AA, et al. Novel immortalized human fetal liver cell line, cBAL111, has the potential to differentiate into functional hepatocytes. BMC Biotechnol 2009; 9: 89.
28. van de Kerkhove MP, Poyck PP, van Wijk AC, et al. Assessment and improvement of liver specific function of the AMC-bioartificial liver. Int J Artif Organs 2005; 28: 617-30.
29. van Eijk HM, van der Heijden MA, van Berlo CL, et al. Fully automated liquid-chromatographic determination of amino acids. Clin Chem 1988; 34: 2510-13.
30. Boehm O, Zur B, Koch A, et al. Clinical chemistry reference database for Wistar rats and C57/BL6 mice. Biol Chem 2007; 388: 547-54.
31. Imler M, Frick A, Schlienger JL, et al. An automated microassay for blood ammonia. J Clin Chem Clin Biochem 1979; 17: 247-50.
32. Hargrove JL, Schmidt FH. The role of mRNA and protein stability in gene expression. FASEB J 1989; 3: 2360-70.
33. Chang R, Chicoine LG, Cui H, et al. Cytokine-induced arginase activity in pulmonary endothelial cells is dependent on Src family tyrosine kinase activity. Am J Physiol Lung Cell Mol Physiol 2008; 295: L688-L97.
34. Morris SM Jr, Kepka-Lenhart D, Chen LC. Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. Am J Physiol 1998; 275: E740-E47.
35. Li Y, Dong JB, Wu MP. Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice. Eur J Pharmacol 2008; 590: 417-22.
36. Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 2003; 290: 2292-300.
37. Haas MJ, Horani M, Mreyoud A, et al. Suppression of apolipoprotein AI gene expression in HepG2 cells by TNF alpha and IL-1beta. Biochim Biophys Acta 2003; 1623: 120-28.
38. Srivastava RA, Srivastava N, Averna M. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism. Eur J Biochem 2000; 267: 4272-80.
39. Dabos KJ, Whalen HR, Newsome PN, et al. Impaired gluconeogenesis in a porcine model of paracetamol induced acute liver failure. World J Gastroenterol 2011; 17: 1457-61.